↓ Skip to main content

Oncotarget

Therapeutic response and side effects of repeated radioligand therapy with 177 Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer

Overview of attention for article published in Oncotarget, February 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
1 patent

Citations

dimensions_citation
230 Dimensions

Readers on

mendeley
152 Mendeley